INS and diabetes mellitus: In summary, we have defined the molecular pathogenesis of MIDY as a syndrome in which mutant proinsulins use unpaired cysteine residues to recruit nonmutant proinsulins into disulfide-linked complexes, blocking insulin production that leads to insulin-deficiency, beta cell ER stress, and diabetes.